Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Antioxidant defense and redox enzymes represent a broad network of proteins, including superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), which are essential for maintaining cellular redox homeostasis (Source: NIH). These enzymes function by neutralizing reactive oxygen species (ROS) and reactive nitrogen species (RNS), thereby preventing oxidative damage to critical cellular components like DNA, proteins, and lipids (Source: StatPearls). Dysregulation of these systems is a hallmark of various pathologies, including cancer, where it can promote tumor survival, and neurodegenerative diseases like Alzheimer's, where oxidative stress drives neuronal loss (Source: PubMed). Therapeutic strategies often target this system by using small molecule mimetics or by inducing the Nrf2 pathway to enhance the expression of multiple antioxidant genes (Source: Nature Reviews Drug Discovery). However, because this term refers to a functional category of enzymes rather than a single druggable protein, it is classified as a target class rather than a specific molecular target (Source: UniProt). The complexity of the redox network means that affecting one enzyme can have compensatory effects on others, making the development of targeted therapies challenging (Source: PubMed). Furthermore, the 'antioxidant paradox' suggests that excessive suppression of ROS can interfere with essential physiological signaling pathways, such as those involved in insulin sensitivity and immune defense (Source: NIH). Consequently, while these enzymes are critical for health, they must be targeted with high specificity to avoid disrupting normal cellular functions (Source: Nature Reviews Drug Discovery).
These enzymes catalyze the reduction of reactive oxygen species (ROS) or the maintenance of thiol-disulfide exchange to prevent oxidative damage to cellular components (Source: StatPearls).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antioxidant defense and redox enzymes.